Treatment of Pain Associated With Fibromyalgia

PHASE3CompletedINTERVENTIONAL
Enrollment

1,301

Participants

Timeline

Start Date

January 16, 2015

Primary Completion Date

January 6, 2017

Study Completion Date

January 12, 2017

Conditions
Pain Associated With Fibromyalgia
Interventions
DRUG

DS-5565

DS-5565 15 mg QD or BID; tablet for oral use

DRUG

Pregabalin

Pregabalin capsule for oral use; 75 mg capsule for one week, then 150 mg capsule

DRUG

Placebo tablet

Placebo tablet for oral use, matching DS-5565 tablet

DRUG

Placebo capsule

Placebo capsule for oral use, matching pregabalin capsule

Trial Locations (154)

1090

Vienna

3541

Senftenberg

11230

Brooklyn

23235

Richmond

30060

Marietta

32132

Edgewater

32720

DeLand

32807

Orlando

32960

Vero Beach

33016

Hialeah

33319

Lauderdale Lakes

33486

Boca Raton

33774

Largo

35242

Birmingham

37064

Franklin

37421

Chattanooga

37912

Knoxville

44130

Middleburg Heights

48104

Ann Arbor

58701

Minot

70119

New Orleans

77024

Houston

78756

Austin

85020

Phoenix

90712

Lakewood

90717

Lomita

91324

Northridge

91723

Covina

91786

Upland

91950

National City

92020

El Cajon

92646

Huntington Beach

98007

Bellevue

99352

Richland

423303

Owensboro

Unknown

Huntsville

Scottsdale

Tempe

Tucson

Anaheim

Encino

Los Angeles

Oceanside

Sacramento

Walnut Creek

Fort Lauderdale

Fort Myers

Maitland

Miami

Sunrise

Tamarac

Tampa

West Palm Beach

Winter Haven

Winter Park

Dawsonville

Smyrna

Chicago

Evansville

Granger

Overland Park

Lake Charles

Frederick

Brockton

North Dartmouth

Ann Arbor

Lansing

Rochester Hills

Florissant

Hazelwood

O'Fallon

Bellevue

Newington

Albuquerque

Cedarhurst

Rochester

Charlotte

Raleigh

Winston-Salem

Cincinnati

Columbus

Dayton

Oklahoma City

Portland

Altoona

Media

Wyomissing

Greenville

Mt. Pleasant

Memphis

Lake Jackson

San Antonio

Norfolk

CABA

La Plata

Lanús

Mar del Plata

Quilmes

San Fernando

Rosario

Córdoba

San Miguel de Tucumán

Santa Fe

Klagenfurt

Minsk

Vitebsk

Brussels

Edegem

Gozée

Oostham

Antofagasta

Providencia

Puerto Varas

Viña del Mar

Barranquilla

Bogotá

Haifa

Kfar Saba

Ramat Gan

Tel Aviv

Cuautitlán Izcalli

Durango

Guadalajara

León

Mexico City

Elblag

Gdansk

Katowice

Krakow

Lublin

Nadarzyn

Nowa Sól

Torun

Tychy

Warsaw

Aveiro

Braga

Guimarães

Lisbon

Ponte de Lima

Porto

Vila Nova de Gaia

Ljubljana

Slovenj Gradec

Alicante

Barcelona

Elche

Granada

Guadalajara

Madrid

Santiago de Compostela

Seville

Geneva

Sankt Gallen

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Syneos Health

OTHER

lead

Daiichi Sankyo

INDUSTRY

NCT02187471 - Treatment of Pain Associated With Fibromyalgia | Biotech Hunter | Biotech Hunter